Coeptis Therapeutics Ownership | Who Owns Coeptis Therapeutics?


OverviewRevenueFinancialsChart

Coeptis Therapeutics Ownership Summary


Coeptis Therapeutics is owned by 0.15% institutional investors, 13.39% insiders, and 86.46% retail investors. Anchor investment management is the largest institutional shareholder, holding 0.19% of COEP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 4.45% of its assets in Coeptis Therapeutics shares.

COEP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCoeptis Therapeutics0.15%13.39%86.46%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Anchor investment management7.00K0.19%$122.22K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Anchor investment management7.00K0.01%$122.22K

Top Buyers

HolderShares% AssetsChange
Anchor investment management7.00K0.01%7.00K

Top Sellers

HolderShares% AssetsChange
Anchor investment management7.00K0.01%7.00K

New Positions

HolderShares% AssetsChangeValue
Anchor investment management7.00K0.01%7.00K$122.22K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20251-7,000--413.77%--100.00%--
Sep 30, 20251-7,000---1---
Dec 31, 20241-92.86%2,250-99.87%-0.03%--100.00%1-66.67%
Sep 30, 202414-17.65%1,706,1411.72%423.34%4-33.33%3-
Jun 30, 202417-15.00%1,677,279-64.64%42.87%6-33.33%350.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv256.55K4.45%-11.54K
Vanguard Institutional Extnd Mkt Idx Tr42.37K0.74%-
Fidelity Extended Market Index21.64K0.38%219.00
Blackrock Extended Mkt Fund CF13.35K0.23%13.35K
Extended Equity Market Fund K11.45K0.20%11.45K
NT Ext Equity Mkt Idx Fd - L6.94K0.12%4.41K
Fidelity Total Market Index6.21K0.11%-
Fidelity Series Total Market Index5.17K0.09%-
NT Ext Equity Mkt Idx Fd - NL5.13K0.09%-
Spartan Extended Market Index Pool F4.70K0.08%41.00

Recent Insider Transactions


DateNameRoleActivityValue
Jan 10, 2024Cogley Brian Chief Financial OfficerBuy$3.35K
Jan 12, 2024DeSilva Tara-Buy$260.96
Jan 12, 2024DeSilva Tara-Buy$1.04K
Jan 05, 2024Yerace Daniel Alexander VP of OperationsBuy$7.49K
Jan 05, 2024Salkind Gene-Buy$8.00K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q19-
2023 Q4--
2023 Q34-

COEP Ownership FAQ


Who Owns Coeptis Therapeutics?

Coeptis Therapeutics shareholders are primarily institutional investors at 0.15%, followed by 13.39% insiders and 86.46% retail investors. The average institutional ownership in Coeptis Therapeutics's industry, Biotech Stocks , is 382.13%, which Coeptis Therapeutics falls below.

Does Blackrock own Coeptis Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Coeptis Therapeutics.

Who is Coeptis Therapeutics’s biggest shareholder by percentage of total assets invested?

Anchor investment management is Coeptis Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 7K Coeptis Therapeutics shares, valued at 122.22K$.

Who is the top mutual fund holder of Coeptis Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Coeptis Therapeutics shares, with 4.45% of its total shares outstanding invested in 256.55K Coeptis Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools